4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

October 2021 | 43 pages | ID: 4FF8D61A4D9EN
GlobalData

Abstracts

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

4SC AG (4SC) is a biopharmaceutical company that develops small molecule drugs for the treatment of cancer. The company’s product portfolio focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its small molecule product pipeline comprises of Resminostat and Domatinostat (4SC-202), both are histone deacetylase (HDAC) inhibitor. The company’s research programs are related to cancer stem cells, ion channel blockers and cytokine modulation. It develops and commercializes its products through partnerships and collaborations with pharmaceutical and biotech companies mainly in the European and Asian markets. 4SC is headquartered in Planegg-Martinsried, Germany.

4SC AG Key Recent Developments

Apr 20,2021: 4SC provides Q1 2021 update
Oct 20,2020: 4SC provides Q3 business update and outlook

2020
Apr 21,2020: 4SC provides Q1 2020 update
Mar 25,2020: 4SC AG provides results for financial year 2019 and outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

4SC AG - Key Facts
4SC AG - Key Employees
4SC AG - Key Employee Biographies
4SC AG - Major Products and Services
4SC AG - History
4SC AG - Company Statement
4SC AG - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
4SC AG - Business Description
Geographical Segment: EU (Without Germany)
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other Countries
Performance
4SC AG - Corporate Strategy
4SC AG - SWOT Analysis
SWOT Analysis - Overview
4SC AG - Strengths
4SC AG - Weaknesses
4SC AG - Opportunities
4SC AG - Threats
4SC AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
4SC AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
4SC AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 20, 2021: 4SC provides Q1 2021 update
Oct 20, 2020: 4SC provides Q3 business update and outlook- 2020
Apr 21, 2020: 4SC provides Q1 2020 update
Mar 25, 2020: 4SC AG provides results for financial year 2019 and outlook

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

4SC AG, Key Facts
4SC AG, Key Employees
4SC AG, Key Employee Biographies
4SC AG, Major Products and Services
4SC AG, History
4SC AG, Key Competitors
4SC AG, Ratios based on current share price
4SC AG, Annual Ratios
4SC AG, Annual Ratios (Cont...1)
4SC AG, Interim Ratios
4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
4SC AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
4SC AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

4SC AG, Performance Chart (2016 - 2020)
4SC AG, Ratio Charts
4SC AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
4SC AG, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021